SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue GuidanceGlobeNewsWire • Monday
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the PelvisGlobeNewsWire • 09/28/26
SI-BONE, Inc. (SIBN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026GlobeNewsWire • 08/31/26
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to TradeZacks Investment Research • 08/24/26
Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?Zacks Investment Research • 08/06/26
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 GuidanceGlobeNewsWire • 08/03/26
ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its BoardGlobeNewsWire • 07/14/26
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026GlobeNewsWire • 06/04/26
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' NowZacks Investment Research • 06/03/26
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should KnowZacks Investment Research • 06/01/26
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%Zacks Investment Research • 05/15/26
SI-BONE, Inc. (SIBN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/12/26